EP
MEDP icon

Edgestream Partners’s Medpace MEDP Stock Holding History

Edgestream Partners’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,752
Closed -$1.8M – 1072
2026
Q1 		$1.8M Sell
3,752
-1,647
-31% -$843K 0.06% 522
2025
Q4 		$3.03M Buy
5,399
+3,786
+235% +$2.15M 0.09% 420
2025
Q3 		$829K Sell
1,613
-24,618
-94% -$10.7M 0.02% 656
2025
Q2 		$8.23M Buy
26,231
+4,793
+22% +$1.44M 0.23% 132
2025
Q1 		$6.53M Buy
21,438
+2,139
+11% +$720K 0.22% 154
2024
Q4 		$6.41M Sell
19,299
-7
-0% -$2.37K 0.27% 85
2024
Q3 		$6.44M Buy
19,306
+6,235
+48% +$2.37M 0.28% 82
2024
Q2 		$5.38M Buy
+13,071
New +$5.18M 0.26% 105
2024
Q1 		– Sell
-1,750
Closed -$536K – 940
2023
Q4 		$536K Sell
1,750
-3,647
-68% -$984K 0.04% 596
2023
Q3 		$1.31M Buy
+5,397
New +$1.38M 0.1% 312
2023
Q2 		– Sell
-9,937
Closed -$1.87M – 832
2023
Q1 		$1.87M Buy
+9,937
New +$2.06M 0.21% 161

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Edgestream Partners's MEDP Position: Q2 2026 in Review

Edgestream Partners sold out of Medpace (MEDP) in Q2 2026, closing a stake of 3,752 shares — an estimated $1.8M sold.

Edgestream Partners first reported a position in MEDP in Q1 2023 and held it in 11 quarters. The position peaked at $8.23M in Q2 2025. 696 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Edgestream Partners reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
  • Edgestream Partners sold 3,752 Medpace shares in Q2 2026, an estimated $1.8M.
  • Edgestream Partners first reported a position in Medpace in Q1 2023 and held it in 11 quarters.
  • Edgestream Partners's Medpace position peaked at $8.23M in Q2 2025.
  • 696 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Edgestream Partners's 13F filing for Q2 2026, filed 11 Aug 2026.